Tumor proliferation index. its value for prediction of therapeutic response in breast cancers
Magdelénat, H.; Remvikos, Y.; Vielh, P.
Pathologie-Biologie 38(8): 780-781
1990
ISSN/ISBN: 0369-8114 PMID: 2274353 Document Number: 366638
Document emailed within 1 workday
Related Documents
Miglietta, L.; Vanella, P.; Canobbio, L.; Parodi, M.A.; Guglielmini, P.; Boccardo, F. 2009: Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index Anticancer Research 29(5): 1621-1625Blok, Rław.; Blok, K.; Gryboś, M.; Klimkiewicz, D.; Jeleń-Krzeszewska, J.; Latkowski, K. 2004: Assessment of cell proliferation based on group analysis of Ki-67 index in serous ovarian cancers Ginekologia Polska 75(10): 776-784
Charpin, C.; Habib, M.C.; Piana, L.; Rampal, M.; Andrac, L.; Vacheret, H.; Martini, P.; Perez-Castillo, M.; Lavaut, M.N.; Toga, M. 1989: Growth fraction (Ki67), ploidy balance and proliferation index in tumors of the urogenital tract and breast Annales de Pathologie 9(5): 331-339
Maciejewski, B.; Skladowski, K.; Zajusz, A. 1991: Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers Neoplasma 38(5): 513-522
Coombes, R.C.; Powles, T.J.; Berger, U.; Wilson, P.; McClelland, R.A.; Gazet, J.C.; Trott, P.A.; Ford, H.T. 1987: Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates Lancet 2(8561): 701-703
Evangelista, L.; Cervino, A.R.; Michieletto, S.; Saibene, T.; Orvieto, E.; Bozza, F.; Ghiotto, C. 2017: Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 61(2): 205-215
Nardelli, G.B.; Lamaina, V.; Siliotti, F. 1986: Estrogen and progesterone receptors status in the prediction of response of breast cancer to endocrine therapy (preliminary report) European Journal of Gynaecological Oncology 7(3): 151-158
Selmaj, K.W.; Farooq, M.; Norton, W.T.; Raine, C.S.; Brosnan, C.F. 1990: Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor Journal of Immunology 144(1): 129-135
Yu, N.Y.; Conway, C.; Pena, R.L.S.; Chen, J.Y. 2007: STEALTH liposomal CKD-602, a topoisomerase I inhibitor, improves the therapeutic index in human tumor xenograft models Anticancer Research 27(4B): 2541-2545
Gabizon, A.A. 1992: Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes Cancer Research 52(4): 891-896
Tisman, G.; Herbert, V.; Edlis, H. 1973: Determination of therapeutic index of drugs by in vitro sensitivity tests using human host and tumor cell suspensions Cancer ChemoTherapy Reports 57(1): 11-19
Reisbach, G.; Gebhart, E.; Cailleau, R. 1982: Sister chromatid exchanges and proliferation kinetics of human metastatic breast tumor cells lines Anticancer Research 2(4): 257-260
Zubrikhina, G.N.; Ermilova, V.D.; Kuz'mina, Z.V.; Bassalyk, L.S. 1989: Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer Arkhiv Patologii 51(3): 10-16
Shackney, S.E.; Pollice, A.A.; Smith, C.A.; Alston, L.; Singh, S.G.; Janocko, L.E.; Brown, K.A.; Petruolo, S.; Groft, D.W.; Yakulis, R.; Hartsock, R.J. 1996: The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications Cancer Journal from Scientific American 2(2): 106-113
Hellman, S. 1980: Improving the therapeutic index in breast cancer treatment: the Richard and Hinda Rosenthal Foundation Award lecture Cancer Research 40(12): 4335-4342
Toner, G.C.; Geller, N.L.; Tan, C.; Nisselbaum, J.; Bosl, G.J. 1990: Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors Cancer Research 50(18): 5904-5910
DeWys, W.D.; Allegra, J.C.; Simon, R.; Lippman, M.B. 1980: A proposed model for the prediction of response to endocrine therapy in breast cancer from the estrogen receptor status of one site and the number of metastatic sites Cancer Research 40(7): 2423-2427
Bethune, C.R.; Geyer, R.J.; Spence, A.M.; Ho, R.J. 2001: Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats Cancer Research 61(9): 3669-3674
Zimin, A.; Samoĭlova, K.A.; Zhevago, N.A. 2010: Proliferation of normal and tumor cells at the presence of serum from patients with breast cancer after phototherapy with visible and near infrared light Tsitologiia 52(9): 785-792
Ke, F.; Wu, J.-M.; Yao, J.-E.; Bai, Y.-J.; Guo, A.-L. 2007: Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis Zhonghua Yi Xue Za Zhi 87(32): 2257-2261